Daniel Kendall, Digital Health Today, Healtcare, Podcast

In this episode, I spoke to Molly K. McCarthy MBA, BSN, RN-BC. Molly is the National Director, US Provider Industry and Chief Nursing Officer for Microsoft. Molly shares her path that led her from from nursing to technology leadership. She also discusses the use of the Hololens, education and the 3 key business areas at Microsoft Health, which are: 1) Helping clients migrate to the cloud 2) Helping to empower frontline clinicians 3) Thinking about AI as it applies to further development of precision medicine. Links and Resources: Molly McCarthy on LinkedIn  •  Twitter Smart Equipment Mgmt (Stryker) HoloLens in Germany (Virtual Surgery Intelligence) Microsoft Health  Website •  Twitter 

Daniel Kendall, Digital Health Today, digital healthcare

I recently had the opportunity to travel to Berlin Germany for the Bayer G4A Signing Day event. This was their official launch of the 11 inspiring companies that are the most recent additions to the G4A family. While I was there, I was fortunate to have the opportunity to speak with their keynote speaker for the evening. From the stage, he shared the story behind the success of his company, the impact it’s having in real and powerful ways, and the focus on the company following their IPO in July of this year.That speaker was none other than Glen Tullman, the Executive Chairman and Founder of Livongo Health. Unless you’ve been living under a rock the past few years, you’ve heard about Livongo and the work they’re doing as a consumer-first, digital health company that’s committed to empowering people with chronic conditions to live better and healthier lives. Glen and I spoke about his mission to finding a cure for diabetes and other chronic conditions, and to keeping people healthy until these cures are found. Before Livongo, Glen previously ran two public companies that changed the way health care is delivered, and he is the author of a book entitled: On Our Terms: Empowering the New Health Consumer. In that book, he proposes new solutions to address the chronic-condition epidemic we’re facing.And while he’s achieved great success in business, he’s also a strong advocate of philanthropic causes. He was honored just this year with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system.He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member of the American Diabetes Association.In addition to all this, Glen is a father to three amazing children that inspire him every day. I was inspired by our conversation, and I hope you’ll enjoy it as much as I did.

Daniel Kendall, Digital Health Today, digital medicine, Podcast

The use of the term ‘digital health’ is continuing to grow, with new subsets of products and services being grouped within it: digital doctor’s visits, digital clinical trials, digital therapeutics, and digital medicine – these are just some of the terms that have burst onto the scene. In this episode, we’re diving into one of the terms in the digital health lexicon: ‘digital medicine’. We explore what digital medicine is, how it is positioned along with digital therapeutics and digital health, and explore what’s needed to make the field of digital medicine stronger, smarter and faster.My guest is Jen Goldsack, the Interim Executive Director of the Digital Medicine Society, a new organization that’s just been launched. Jen has a background in clinical trials, outcomes research, and innovation, and she holds masters degrees from the University of Oxford in England, the University of Pennsylvania, and an MBA from George Washington University. Jen is also a retired athlete; she is a Pan American Games Champion, Olympian and World Championship silver medalist. She’s a dual-national with both British and American citizenship, and currently resides in Florida. Jen also shares her journey from being an elite athlete to the elite field of healthcare, and her motivation for making a real difference to both individuals and populations.

Dan Kendall, Digital Health Today, Podcast

How a former F-16 fighter pilot is flying high with new FDA and CE-registered medical applications using VR~ Virtual Reality, Augmented Reality, Mixed Reality – We’ve spoken to leaders about these technologies in our conversations with Dr. Brennan Spiegel, Dr. Ashya Vahabzadeh, Dr. Shafi Ahmed, Dr. Rafael Grossman and Dr. Justin Barad. Those guests, who all happened to be doctors leading in the field, spoke about their work across a wide variety of use cases, such as patient education, treating mental health condition, pain management, surgical training and actual live surgery. In this episode, we discuss what makes VR such a powerful tool in health care, and tips on how to start a medical device company with no previous medical device or startup experience. We also dive into how the business was helped by getting the FDA involved early.  Finally, we also discuss how VR bridges therapy from the hospital to the home, and some of the applications for motor and cognitive treatment, disease progression, response to therapy and much more. Eran Orr is the CEO and Founder of XR Health, an Israeli company with offices in Boston, Massachusetts. XR Health creates an extended-reality platform that combines medical applications with advanced data analytics to provide a comprehensive solution for clinicians and patients. XRHealth is the first Certified Virtual Reality Medical Company to develop FDA/CE Registered Medical Applications. Their products focus on motor, cognitive, physical, psychological, postural ability and pain assessment and treatment.

Daniel Kendall, Digital Health Today, Podcast

Our guest is Francesca Wuttke, PhD, the Chief Digital Officer of Almirall. Almirall is an international pharmaceutical company founded in 1943 and based in Barcelona – which is where Francesca is based.Francesca is responsible for developing and executing an end-to-end company-wide digital transformation. In her role, she is responsible for finding use cases to apply digital solutions and services across the business and bring efficiencies that save time, lower costs and open up new business channels for Almirall.  Francesca has over 20 years of drug development and healthcare expertise in both the US and Europe, and most recently, she led European investments as Managing Director for the MSD Global Health Innovation Fund and previously held roles at Novartis and Mount Sinai school of medicine, just to name a few. Francesca holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences. In this conversation, Francesca shares her insights on what is being done, and what needs to be done, to accelerate innovation within pharma. Francesca also references a great document called the 12 Commandments for Startup and Corprate Relationships (Click the link below). And finally, she gave us a little insight into a new accelerator program that they’ve developed: the Digital Garden Powered by Almirall. If you want to know more about that program when it is launched in the next few months, be sure to subscribe to our newsletter.